CardioKinetix Inc.
Related Content
Feature | January 18, 2013
CardioKinetix Inc. announced the enrollment of the first patients in PARACHUTE IV, the randomized pivotal U.S. trial of...
The first-of-its-kind catheter-based Parachute(TM) Ventricular Partitioning Device for patients with ischemic heart failure. Clinical data from two first-in-human studies of the Parachute system show meaningful and sustained low clinical events for patients with ischemic heart failure two years following treatment with the device.
News | May 22, 2012
May 22, 2012 — CardioKinetix Inc. announced two-year clinical results for the first-of-its-kind catheter-based...
News | March 20, 2008
March 21, 2008 – A central Ohio man has become the first person in the U.S., and only the 16th worldwide, to receive
